Skip to content

Clinical trials

Phase 1/2 Glioblastoma trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 1/2 Country / region: Spain Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20111
20131
20141
20163
20182
20203
20233
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting4
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Grupo Español de Investigación en Neurooncología2
Novartis Pharmaceuticals2
Bayer1
Cantex Pharmaceuticals1
Celgene1
Debiopharm International SA1
Enterome1
Forma Therapeutics, Inc.1
Fundación de investigación HM1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma19
Brain Neoplasms4
Glioma4
Carcinoma, Hepatocellular3
Ependymoma3
Gliosarcoma3
Osteosarcoma3
Carcinoma, Non-Small-Cell Lung2
Diffuse Intrinsic Pontine Glioma2
Medulloblastoma2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.